Clinical Trial

aPBI Re-irradiation

Name: aPBI Re-irradiation — clinical trial record (NCT07612254)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: REPEAT

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This study is to determine whether acute treatment-associated adverse events following breast re-irradiation with aPBI are acceptably low and to assess local control following breast re-irradiation with aPBI. An exploratory aim is to assess cosmetic outcomes following breast re-irradiation with aPBI.

Trial Details

NCT Number	NCT07612254
Lead Sponsor	Dartmouth-Hitchcock Medical Center
Conditions	Breast Cancer Recurrent
Enrollment	30 participants
Start Date	2026-06-03
Primary Completion	2032-04-28 (estimated)
Study Completion	2033-04 (estimated)
Updated on ClinicalTrials.gov	2026-05-28